The disease is thought to be divided into two subtypes, depending on where it originates in the body — the gut or the brain.

After decades of work, researchers have begun trialling transplants of dopamine neurons into people with the ...

Kinase inhibitors have transformed cancer treatment, but resistance mutations and off-target toxicity continue to limit their ...

Neuroscientists are developing a new type of brain implant that will decode every movement and symptom of people with this ...

But many neurologists and Parkinson’s advocates think that the science is sufficient to link some chemicals to the condition.

Brains are resilient. Harnessing their self-protective mechanisms might help to prevent or slow the progression of this ...

Marcus died from complications of Parkinson’s disease on 26 August. He lived with the condition, which affects 8–12 million ...

Most Parkinson’s therapies aim to reduce the motor-control symptoms that the disease triggers. But stem-cell transplants in ...

He couldn’t admit that the great, all-knowing oracle of the cosmos had just read him a treatise on sock friction. He had paid ...

Immune checkpoint inhibitors (CPIs) have transformed cancer treatment, but resistance and limited response rates have driven ...

The latest cases, in the Democratic Republic of the Congo, come as the country grapples with ongoing Ebola and cholera ...

Scientists have developed a new class of light-responsive metal-based antibiotics that can fight biofilm-forming harmful ...